WORLD Russia's Sputnik V vaccine 91.6% effective: Lancet study


Russia's Sputnik V vaccine 91.6% effective: Lancet study


20:33, February 02, 2021

In this file photo taken on January 20, 2021 people queue to receive an injection of Russia's Sputnik V (Gam-COVID-Vac) vaccine against the coronavirus disease at a vaccination point at the GUM department store in Moscow, days after Russia launched mass coronavirus vaccinations. (Photo: AFP)

Russia's Sputnik V vaccine is 91.6 percent effective against symptomatic Covid-19, according to an analysis published in The Lancet on Tuesday that independent experts said allayed transparency concerns over the jab, which Moscow is already rolling out.

The preliminary findings show that the two-dose Sputnik V "has shown high efficacy" and was well tolerated for participants over 18 in final-stage clinical trials, said co-lead author Inna Dolzhikova of Russia's Gamaleya National Research Centre for Epidemiology and Microbiology.

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue